We recently sat down with members of the SGD Pharma and PAI teams to talk about how they are converting an ambitious plan – to accelerate growth, refine and enrich the product mix, reinforce existing talent, and position SGD Pharma at the forefront of the decarbonisation of the glass pharma industry – into reality.

In this short video, we hear from SGD Pharma CEO Olivier Rousseau and other members of the team, together with members of the PAI Investment Team and PAI Performance Group (PPG), who talk about the subtle partnership between our respective teams and how it is one of the key success factors in the delivery of SGD Pharma’s transformation journey.